Neopterin and RANTES content in serum of patients with infiltrative and disseminated tuberculosis

DOI: https://doi.org/10.29296/25877305-2022-02-09
Issue: 
2
Year: 
2022

Associate Professor O. Chelnokova(1), MD; Professor A. Baranov(1), MD; А. Takhkhan(2)
(1)Yaroslavl State Medical University of the Ministry of Healthcare of Russia (2)Yaroslavl Regional Clinical
Tuberculosis Hospital

The problem of tuberculosis (TB) remains a priority in public health worldwide and in the Russian Federation. Approaches to diagnosis and treatment are being improved. There are scientific background for using neopterin and RANTES as integral indicators of TB current severity, but more research is need in this area. Objective. To study RANTES and neopterin content in blood serum of patients with destructive infiltrative and disseminated TB to distinguish a group of patients with acute progression. Material and methods. The content of neopterin and RANTES in 72 patients with destructive infiltrative and disseminated TB and 30 healthy donors was studied by enzyme immunoassay. The TB patients were divided into 2 groups: 36 patients with acute progression and 36 patients without signs of acute progression. Results. The serum levels of neopterin and RANTES were significantly increased in patients with infiltrative and disseminated TB. Herewith the level of increase correlates with the severity of the progression. The increase of neopterin was found to correlate with the infiltration area and destruction size as well as with the increase of C-reactive protein and erythrocyte sedimentation rate (ESR). RANTES increase correlated with infiltration area, destruction size and ESR. Conclusion. The results of the study allow to consider increase of neopterin and RANTES contents as additional objective criteria of acute progression of infiltrative and disseminated TB.
Keywords: 
phthisiology
neopterin
RANTES
acute progression tuberculosis
infiltrative tuberculosis
disseminated tuberculosis

References: 
  1. Vasil'eva I.A., Belilovskij E.M., Borisov S.E. i dr. Zabolevaemost', smertnost' i rasprostranennost' kak pokazateli bremeni tuberkuleza v regionah VOZ, stranah mira i v Rossijskoj Federatsii. Tuberkulez i bolezni legkih. 2017; 95 (6): 9–21 [Vasilyeva I.A., Belilovsky E.M., Borisov S.E. et al. Incidence, mortality and prevalence as indicators of tuberculosis burden in who regions, countries of the world and the Russian Federation. Part 1. Tuberculosis incidence and prevalence. Tuberculosis and Lung Diseases. 2017; 95 (6): 9–21 (in Russ.)]. DOI: 10.21292/2075-1230-2017-95-6-9-21
  2. Ergeshov A.E. Tuberkulez v Rossijskoj Federatsii: situatsija, problemy i perspektivy. Vestnik RAMN. 2018; 73 (5): 330–7 [Ergeshov A.E. Tuberculosis in the Russian Federation: Situation, Challenges and Perspectives. Annals of the Russian Academy of Medical Sciences. 2018; 73 (5): 330–7 (in Russ.)]. DOI: 10.15690/vramn1023
  3. Epidemicheskaja situatsija po tuberkulezu v Rossijskoj Federatsii v 2017 g. Federal'nyj tsentr monitoringa protivodejstvija rasprostraneniju tuberkuleza v RF [Epidemicheskaya situatsiya po tuberkulezu v Rossiiskoi Federatsii v 2017 g. Federal’nyi tsentr monitoringa protivodeistviya rasprostraneniyu tuberkuleza v RF (in Russ.)]. URL: https://mednet.ru/images/materials/CMT/tuberkulez-2019.pdf
  4. Erohin V.V., Zemskova Z.S., Shilova M.V. Patologicheskaja anatomija tuberkuleza. M., 2000; 149 s. [Erokhin V.V., Zemskova Z.S., Shilova M.V. Patologicheskaya anatomiya tuberkuleza. M., 2000; 149 s. (in Russ.)].
  5. Kudlaj D.A. Biomarkery i immunologicheskie testy. Eksperimental'no-klinicheskie paralleli latentnoj tuberkuleznoj infektsii. Tuberkulez i bolezni legkih. 2020; 98 (8): 63–74 [Kuday D.A. Biomarkers and immunological tests. Experimental and clinical parallels of latent tuberculosis infection. Tuberculosis and Lung Diseases. 2020; 98 (8): 63–74 (in Russ.)]. DOI: 10.21292/2075-1230-2020-98-8-63-74
  6. Homenko A.G., Mishin V.Ju., Chukanov V.I. i dr. Diagnostika, klinika i taktika lechenija ostroprogressirujuschih form tuberkuleza legkih v sovremennyh epidemiologicheskih uslovijah. Problemy tuberkuleza. 1999; 1: 22–7 [Khomenko A.G., Mishin V.Yu., Chukanov V.I. et al. Diagnostika, klinika i taktika lecheniya ostroprogressiruyushchikh form tuberkuleza legkikh v sovremennykh epidemiologicheskikh usloviyakh. Problemy tuberkuleza. 1999; 1: 22–7 (in Russ.)].
  7. Churina E.G., Sitnikova A.V., Urazova O.I. i dr. Makrofagi pri bakterial'nyh boleznjah legkih: fenotip i funktsii (obzor). Bjulleten' sibirskoj meditsiny. 2019; 18 (1): 142–54 [Churina E.G., Sitnikova A.V., Urazova O.I. et al. Macrophages in bacterial lung diseases: phenotype and functions (review). Bulletin of Siberian Medicine. 2019; 18 (1): 142–54. (in Russ.)]. DOI: 10.20538/1682-0363-2019-1-142-154
  8. Esmedljaeva D.S., Alekseeva N.P., Pavlova M.V. i dr. Neopterin syvorotki krovi kak integral'nyj pokazatel' aktivnosti protsessa u bol'nyh infil'trativnym tuberkulezom legkih. Meditsinskij al'jans. 2016; 2: 20–5 [Esmedlyaeva D.S., Alexeeva N.P., Pavlova M.V. et al. Serum neopterin as an integral indicator of process activity in patients with infiltrative pulmonary tuberculosis. Meditsinskii al’yans. 2016; 2: 20–5 (in Russ.)].
  9. Eisenhut M. Neopterin in Diagnosis and Monitoring of Infectious Diseases. J Biomark. 2013; 2013: 196432. DOI: 10.1155/2013/196432
  10. Zhao Y., Yang X., Zhang X. et al. IP-10 and RANTES as biomarkers for pulmonary tuberculosis diagnosis and monitoring. Tuberculosis (Edinb). 2018; 111: 45–53. DOI: 10.1016/j.tube.2018.05.004
  11. Schall T.J. Biology of the RANTES/SIS cytokine family. Cytokine. 1991; 3 (3): 165–83. DOI: 10.1016/1043-4666(91)90013-4
  12. Gunja Mishra, Satish S. Poojary, Sanjay Jain et al. Genotype-phenotype relationship of CCL5 in pulmonary tuberculosis infection in Sahariya tribe: A pilot study. Indian J Med Res. 2017; 146 (6): 768–73. DOI: 10.4103/ijmr.IJMR_1582_15
  13. Erohin V.V., Mishin V.Ju., Chukanov V.I. i dr. Kazeoznaja pnevmonija. M.: Meditsina, 2008; 191 s. [Erokhin V.V., Mishin V.Yu., Chukanov V.I. et al. Kazeoznaya pnevmoniya. M.: Meditsina, 2008; 191 s. (in Russ.)].
  14. Chelnokova O.G. Osobennosti diagnostiki i lechenija ostroprogressirujuschih destruktivnyh form tuberkuleza legkih. Diss. … d-ra med. nauk. M., 2007; 377 s. [Chelnokova O.G. Osobennosti diagnostiki i lecheniya ostro progressiruyushchikh destruktivnykh form tuberkuleza legkikh. Diss. … d-ra med. nauk. M., 2007; 377 s. (in Russ.)].